News

home News

[231208 저널발표] INPP5D regulates inflammasome activation in human microglia

김지은 │ 2023-12-06

HIT

386

. 2023 Nov 29;14(1):7552.
doi: 10.1038/s41467-023-42819-w.

INPP5D regulates inflammasome activation in human microglia

Affiliations
Free PMC article

Abstract

Microglia and neuroinflammation play an important role in the development and progression of Alzheimer's disease (AD). Inositol polyphosphate-5-phosphatase D (INPP5D/SHIP1) is a myeloid-expressed gene genetically-associated with AD. Through unbiased analyses of RNA and protein profiles in INPP5D-disrupted iPSC-derived human microglia, we find that reduction in INPP5D activity is associated with molecular profiles consistent with disrupted autophagy and inflammasome activation. These findings are validated through targeted pharmacological experiments which demonstrate that reduced INPP5D activity induces the formation of the NLRP3 inflammasome, cleavage of CASP1, and secretion of IL-1β and IL-18. Further, in-depth analyses of human brain tissue across hundreds of individuals using a multi-analytic approach provides evidence that a reduction in function of INPP5D in microglia results in inflammasome activation in AD. These findings provide insights into the molecular mechanisms underlying microglia-mediated processes in AD and highlight the inflammasome as a potential therapeutic target for modulating INPP5D-mediated vulnerability to AD.




Prev [231201 저널발표] Amelioration of Tau and ApoE4-linked glial lipid accumulation...
Next [231208 저널발표] A neurodegeneration checkpoint mediated by REST protects again...